Skip to main content
Caplight Logo









Bionyra Pharma

Bionyra Pharma

Private
ParisHealthcare & Life Scienceshttps://bionyra.com/

Last Round

Series A

Jun 22, 2026

Total Funding Raised

$165M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Bionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation biologics for immune-mediated inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

therapeutic antibodiesbiologicsmonoclonal antibodiesbispecific antibodiesimmunologyclinical-stage biotechinflammatory bowel diseaseIBDatopic dermatitisautoimmune disease treatmenthalf-life extensionHLEdrug developmentbiotech in-licensinganti-TL1Aanti-IL-25

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bionyra Pharma Comparables

Compare Bionyra Pharma with similar companies based on industry and business-model similarity.

Bionyra Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Caldera Therapeutics
89%
TriveniBio
79%
Santa Ana Therapeutics
77%

Bionyra Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 22, 2026
SeedAug 1, 2025

Bionyra Pharma Investors

Notable investors and investment history

Bionyra Pharma investors
InvestorRounds
Sixty Degree CapitalSeries A
VIVES PartnersSeries A
Sanofi VenturesSeries A
Sofinnova PartnersSeries A, Seed
Arkin Bio VenturesSeries A
Jeito CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 22, 2026

    $165M round led by Jeito and Sofinnova Partners.

  • Aug 1, 2025

    Raised a Seed round led by Sofinnova Partners.

Bionyra Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bionyra Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bionyra Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Year Founded2025
Last FundingJun 22, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?